Get the Stockscreener App
0.7299
1.62%
-0.012
After Hours:
.77
0.0401
+5.49%
Iterum Therapeutics Plc stock is traded at $0.7299, with a volume of 823.17K.
It is down -1.62% in the last 24 hours and up +6.95% over the past month.
Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.
See More
Previous Close:
$0.7419
Open:
$0.78
24h Volume:
823.17K
Relative Volume:
0.96
Market Cap:
$34.43M
Revenue:
-
Net Income/Loss:
$-24.08M
P/E Ratio:
-0.8515
EPS:
-0.8572
Net Cash Flow:
$-14.75M
1W Performance:
+4.27%
1M Performance:
+6.95%
6M Performance:
-34.24%
1Y Performance:
-21.52%
1-Day Range:
$0.72
$0.789
1-Week Range:
$0.72
$0.831
52-Week Range:
$0.6108
$3.02
Iterum Therapeutics Plc Stock (ITRM) Company Profile
Name
Iterum Therapeutics Plc
Sector
Industry
Phone
(872) 225-6077
Address
3 DUBLIN LANDINGS, DUBLIN 1
Compare ITRM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ITRM
Iterum Therapeutics Plc
|
0.7299 | 33.13M | 0 | -24.08M | -14.75M | -0.8572 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.37 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.95 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
557.73 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
799.56 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
327.03 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Iterum Therapeutics Plc Stock (ITRM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-28-21 | Upgrade | Gabelli & Co | Sell → Hold |
| Mar-15-21 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Jun-02-20 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Jan-21-20 | Downgrade | Gabelli & Co | Buy → Sell |
| Dec-11-19 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Jun-21-19 | Initiated | H.C. Wainwright | Buy |
View All
Iterum Therapeutics Plc Stock (ITRM) Latest News
Is Iterum Therapeutics plc stock poised for growthIndex Update & AI Driven Stock Movement Reports - newser.com
Chart based analysis of Iterum Therapeutics plc trendsMarket Activity Recap & Entry Point Confirmation Alerts - newser.com
Reversal indicators forming on Iterum Therapeutics plc stockWeekly Gains Summary & Weekly Watchlist for Consistent Profits - newser.com
Is this a good reentry point in Iterum Therapeutics plcEarnings Overview Summary & Weekly Top Stock Performers List - newser.com
Can Iterum Therapeutics plc stock sustain market leadership2025 Winners & Losers & Weekly Return Optimization Alerts - newser.com
Is Iterum Therapeutics plc stock a dividend growth opportunityMarket Volume Summary & Fast Exit and Entry Strategy Plans - newser.com
Iterum Therapeutics plc stock trendline breakdown2025 Key Highlights & High Conviction Investment Ideas - newser.com
Why Iterum Therapeutics plc stock is favored by pension fundsMarket Sentiment Review & Precise Buy Zone Identification - newser.com
Is Iterum Therapeutics plc a good long term investmentContrarian Investment Ideas & Free Stock Market Beginner Guides - earlytimes.in
How Iterum Therapeutics plc stock trades before earningsAnalyst Downgrade & Entry Point Confirmation Signals - newser.com
Technical signs of recovery in Iterum Therapeutics plcQuarterly Earnings Summary & Smart Swing Trading Techniques - newser.com
Multi factor analysis applied to Iterum Therapeutics plcTrade Signal Summary & Technical Pattern Alert System - newser.com
Full technical analysis of Iterum Therapeutics plc stockEarnings Trend Report & Daily Technical Forecast Reports - newser.com
Can Iterum Therapeutics plc stock deliver sustainable ROEJuly 2025 Closing Moves & Smart Swing Trading Alerts - newser.com
Iterum Therapeutics plc Stock Analysis and ForecastVolatility Index Analysis & Affordable Portfolio Growth - earlytimes.in
Volatility clustering patterns for Iterum Therapeutics plcCPI Data & Community Consensus Stock Picks - newser.com
Wall Street Zen Upgrades Iterum Therapeutics (NASDAQ:ITRM) to Hold - Defense World
Iterum Therapeutics Plc Stock (ITRM) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):